Captrust Financial Advisors Ginkgo Bioworks Holdings, Inc. Transaction History
Captrust Financial Advisors
- $30.9 Billion
- Q2 2024
A detailed history of Captrust Financial Advisors transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 18,190 shares of DNA stock, worth $152,614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,190
Previous 15,193
19.73%
Holding current value
$152,614
Previous $17,000
64.71%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DNA
# of Institutions
180Shares Held
685MCall Options Held
990KPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.17 Billion0.0% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$586 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$352 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny31.4MShares$264 Million0.02% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.8B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...